Pharmaceuticals

Prevention, Diagnosis & Treatment

Prevention, Diagnosis & Treatment

Bayer’s brands treat and prevent conditions to improve quality of life.

Pharma News

July 19, 2019

Bayer statement on voluntary recall of two lots of Kogenate® FS antihemophilic factor (recombinant) in the United States

Bayer is voluntarily recalling two lots of Kogenate® FS antihemophilic factor (recombinant) 2000 IU vials in the United States to the patient level. Certain vials from these two lots that were...

Learn more
July 18, 2019

Bayer, Bristol-Myers Squibb and Ono Pharmaceutical enter into a clinical collaboration agreement to investigate Stivarga® (regorafenib) and Opdivo® (nivolumab) as combination therapy in patients with metastatic colorectal cancer

Bayer, Bristol-Myers Squibb Company (NYSE: BMY) and Ono Pharmaceutical Co., Ltd. ('Ono') announced today the three companies have entered into a clinical collaboration agreement to evaluate the...

Learn more
July 17, 2019

Pyxis Oncology Founded by Longwood Fund with Financing Led by Bayer

Pyxis Oncology ('Pyxis'), a newly formed immuno-oncology company, launched today with a focus on developing a new family of antibody-based immunotherapies derived from novel insights into the...

Learn more
Newsroom